# The Pharmaceutical Services (Amendment No. 2) Regulations (Northern Ireland) 2022, Regulation 2: Amendment of the Pharmaceutical Regulations


(1) Regulation 2 of the Pharmaceutical Regulations (interpretation) is amended in accordance with paragraphs (2) to (4).
(2) In paragraph (1)—
(a) omit the definition of “Board”;
(b) in the definition of “dispensing doctor”, for “the Board” substitute “the Department”;
(c) after the definition of “Drug Tariff”, insert—
““FPSIAP” means the Family Practitioner Services Independent Appeal Panel established under regulation 3 of the Health and Social Care (Family Practitioner Services Independent Appeal Panel) Regulations (Northern Ireland) 2022;”;
(d) in the definitions of “Local Dental Committee”, “Local Medical Committee” and “Local Pharmaceutical Committee” for “a Board” substitute “the Department”;
(e) in the definition of “patient list”, for “a Board” substitute “the Department”; and
(f) in the definition of “repeatable prescriber”, for “the Regional Board” substitute “the Department”.
(3) In paragraph (1A) omit “who are in a Board’s area”.
(4) For paragraph (4) substitute—
“(4) In these Regulations, “emergency requiring the flexible provision of pharmaceutical services” means an emergency to the effect that, as a result of the threatened damage to human welfare caused by illness or which may be caused by illness, the Department must for a specified period—
(a) exercise, or
(b) where a discretion is conferred, consider exercising,
one or more of the functions under regulation 6A, 12(7A) or paragraph 4A of Schedule 2 subject to any conditions or limitations.”.

---
Source: https://www.legislation.gov.uk/nisr/2022/116/regulation/2 (the official version)
Page: https://openlegislation.uk/pharmaceutical-services-amendment-no-2-regulations-northern-ireland-2022/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.